PB2155: TARGETING NEUROBIOLOGICAL MECHANISMS IN PATIENTS WITH MULTIPLE MYELOMA HAS IMPROVED THEIR PLASMACYTOID DENDRITIC CELLS CD123+, B LYMPHOCYTE MEMORY CELLS CD27+, VAGAL ACTIVITY AND DISTRESS.

• Pavel Kotoucek,
• Robert Enright,
• Stanislava Gregor Sorgerova,
• Luba Hunakova,
• Veronika Chlebcova,
• Dana Cholujova,
• Jana Jakubikova,
• Boris Mravec,
• Eva Nanistova,
• Ludmila Panekova,
• Jan Sedlak

Affiliations

Pavel Kotoucek

1 Broomfield Hospital, Haematology, Chelmsford, United Kingdom

Robert Enright

3 University of Wisconsin-Madison, Educational Psychology, Madison, United States

Stanislava Gregor Sorgerova

5 Pan European University, Faculty of Psychology, Bratislava, Slovakia

Luba Hunakova

6 Faculty of Medicine (University of Comenius), Institute of Immunology, Bratislava, Slovakia

Veronika Chlebcova

5 Pan European University, Faculty of Psychology, Bratislava, Slovakia

Dana Cholujova

7 Biomedicínske centrum SAV, Cancer Research Institute, Bratislava, Slovakia

Jana Jakubikova

7 Biomedicínske centrum SAV, Cancer Research Institute, Bratislava, Slovakia

Boris Mravec

8 Faculty of Medicine (University of Comenius), Institute of Physiology, Bratislava, Slovakia

Eva Nanistova

5 Pan European University, Faculty of Psychology, Bratislava, Slovakia

Ludmila Panekova

5 Pan European University, Faculty of Psychology, Bratislava, Slovakia

Jan Sedlak

7 Biomedicínske centrum SAV, Cancer Research Institute, Bratislava, Slovakia